4//SEC Filing
Lawton Alison Frances 4
Accession 0001628280-20-014324
CIK 0001501697other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 7:43 AM ET
Size
5.7 KB
Accession
0001628280-20-014324
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Stock Option (right to buy)
2020-10-05+6,854→ 6,854 totalExercise: $7.33Exp: 2030-10-04→ Common Stock (6,854 underlying)
Footnotes (1)
- [F1]33.3333% of the shares subject to the option shall vest on October 5, 2021, with the remainder vesting thereafter in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the grant, subject to the Reporting Person's continued services as a director through each applicable vesting date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001542650
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 7:43 AM ET
- Size
- 5.7 KB